BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07575399-completion@plaintrial.com
DTSTAMP:20261028T195142Z
DTSTART;VALUE=DATE:20280228
SUMMARY:Efficacy\, Safety and Tolerability of Switching From Glucagon-like 
 Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults
  With Obesity or Overweight (MARITIME-SWITCH) — estimated completion dat
 e
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07575399
URL:https://plaintrial.com/trial/NCT07575399
END:VEVENT
END:VCALENDAR
